These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 29977074)
1. The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects. Abdallah CG; De Feyter HM; Averill LA; Jiang L; Averill CL; Chowdhury GMI; Purohit P; de Graaf RA; Esterlis I; Juchem C; Pittman BP; Krystal JH; Rothman DL; Sanacora G; Mason GF Neuropsychopharmacology; 2018 Sep; 43(10):2154-2160. PubMed ID: 29977074 [TBL] [Abstract][Full Text] [Related]
2. ¹H-[¹³C]-nuclear magnetic resonance spectroscopy measures of ketamine's effect on amino acid neurotransmitter metabolism. Chowdhury GM; Behar KL; Cho W; Thomas MA; Rothman DL; Sanacora G Biol Psychiatry; 2012 Jun; 71(11):1022-5. PubMed ID: 22169441 [TBL] [Abstract][Full Text] [Related]
3. Temporal Dynamics of Antidepressant Ketamine Effects on Glutamine Cycling Follow Regional Fingerprints of AMPA and NMDA Receptor Densities. Li M; Demenescu LR; Colic L; Metzger CD; Heinze HJ; Steiner J; Speck O; Fejtova A; Salvadore G; Walter M Neuropsychopharmacology; 2017 May; 42(6):1201-1209. PubMed ID: 27604568 [TBL] [Abstract][Full Text] [Related]
4. Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study. Rowland LM; Bustillo JR; Mullins PG; Jung RE; Lenroot R; Landgraf E; Barrow R; Yeo R; Lauriello J; Brooks WM Am J Psychiatry; 2005 Feb; 162(2):394-6. PubMed ID: 15677610 [TBL] [Abstract][Full Text] [Related]
5. In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept. Rodriguez CI; Kegeles LS; Levinson A; Ogden RT; Mao X; Milak MS; Vermes D; Xie S; Hunter L; Flood P; Moore H; Shungu DC; Simpson HB Psychiatry Res; 2015 Aug; 233(2):141-7. PubMed ID: 26104826 [TBL] [Abstract][Full Text] [Related]
6. Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects. Chowdhury GM; Zhang J; Thomas M; Banasr M; Ma X; Pittman B; Bristow L; Schaeffer E; Duman RS; Rothman DL; Behar KL; Sanacora G Mol Psychiatry; 2017 Jan; 22(1):120-126. PubMed ID: 27067013 [TBL] [Abstract][Full Text] [Related]
7. Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens. Razoux F; Garcia R; Léna I Neuropsychopharmacology; 2007 Mar; 32(3):719-27. PubMed ID: 16525415 [TBL] [Abstract][Full Text] [Related]
8. An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression. Salvadore G; van der Veen JW; Zhang Y; Marenco S; Machado-Vieira R; Baumann J; Ibrahim LA; Luckenbaugh DA; Shen J; Drevets WC; Zarate CA Int J Neuropsychopharmacol; 2012 Sep; 15(8):1063-72. PubMed ID: 22040773 [TBL] [Abstract][Full Text] [Related]
9. Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and "depressed" mice exposed to chronic mild stress. Franceschelli A; Sens J; Herchick S; Thelen C; Pitychoutis PM Neuroscience; 2015 Apr; 290():49-60. PubMed ID: 25595985 [TBL] [Abstract][Full Text] [Related]
10. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Anand A; Charney DS; Oren DA; Berman RM; Hu XS; Cappiello A; Krystal JH Arch Gen Psychiatry; 2000 Mar; 57(3):270-6. PubMed ID: 10711913 [TBL] [Abstract][Full Text] [Related]
12. The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS. Valentine GW; Mason GF; Gomez R; Fasula M; Watzl J; Pittman B; Krystal JH; Sanacora G Psychiatry Res; 2011 Feb; 191(2):122-7. PubMed ID: 21232924 [TBL] [Abstract][Full Text] [Related]
13. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. Moghaddam B; Adams B; Verma A; Daly D J Neurosci; 1997 Apr; 17(8):2921-7. PubMed ID: 9092613 [TBL] [Abstract][Full Text] [Related]
14. Dendritic glutamate-induced bursting in the prefrontal cortex: further characterization and effects of phencyclidine. Shi WX; Zhang XX J Pharmacol Exp Ther; 2003 May; 305(2):680-7. PubMed ID: 12606677 [TBL] [Abstract][Full Text] [Related]
15. Default mode network connectivity change corresponds to ketamine's delayed glutamatergic effects. Li M; Woelfer M; Colic L; Safron A; Chang C; Heinze HJ; Speck O; Mayberg HS; Biswal BB; Salvadore G; Fejtova A; Walter M Eur Arch Psychiatry Clin Neurosci; 2020 Mar; 270(2):207-216. PubMed ID: 30353262 [TBL] [Abstract][Full Text] [Related]
16. Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Lorrain DS; Baccei CS; Bristow LJ; Anderson JJ; Varney MA Neuroscience; 2003; 117(3):697-706. PubMed ID: 12617973 [TBL] [Abstract][Full Text] [Related]
17. Ketamine disrupts neuromodulatory control of glutamatergic synaptic transmission. Lur G; Fariborzi M; Higley MJ PLoS One; 2019; 14(3):e0213721. PubMed ID: 30865708 [TBL] [Abstract][Full Text] [Related]
18. Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study. Taylor MJ; Tiangga ER; Mhuircheartaigh RN; Cowen PJ J Psychopharmacol; 2012 May; 26(5):733-7. PubMed ID: 21616979 [TBL] [Abstract][Full Text] [Related]
19. N-methyl-D-aspartate receptor antagonist effects on prefrontal cortical connectivity better model early than chronic schizophrenia. Anticevic A; Corlett PR; Cole MW; Savic A; Gancsos M; Tang Y; Repovs G; Murray JD; Driesen NR; Morgan PT; Xu K; Wang F; Krystal JH Biol Psychiatry; 2015 Mar; 77(6):569-80. PubMed ID: 25281999 [TBL] [Abstract][Full Text] [Related]
20. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine]. Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L Encephale; 2001; 27(1):53-9. PubMed ID: 11294039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]